MRI-safe IV maker iRadimed sets terms for $10 million IPO

By
A A A

iRadimed, which makes non-magnetic MRI-safe IV infusion pumps, announced terms for its IPO on Wednesday. The Winter Park, FL-based company plans to raise nearly $10 million by offering 1.75 million shares at a price range of $5 to $6. At the midpoint of the proposed range, iRadimed would command a fully diluted market value of $64 million.

iRadimed, which was founded in 1992 and booked $12 million in sales for the 12 months ended March 31, 2014, plans to list on the NASDAQ under the symbol IRMD. iRadimed initially filed confidentially on April 25, 2014. Roth Capital is the sole bookrunner on the deal. A pricing date has not been set.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: IRMD

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

45,852,339
  • $13.77 ▼ 4.38%
40,129,637
  • $45.80 ▲ 1.73%
38,383,882
  • $13.12 ▲ 8.34%
25,581,984
  • $104.82 ▼ 0.01%
23,277,334
  • $11.29 ▲ 4.25%
22,071,708
  • $13.59 ▲ 9.95%
21,058,894
  • $19.75 ▼ 14.58%
20,467,667
  • $16.63 ▲ 0.18%
As of 10/24/2014, 01:03 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com